“BRAINWeek connects the narrative among specialists and clinicians by underscoring the importance of continuity and collaborative patient care. It is on the vanguard of an inevitable paradigm shift among practitioners treating CNS disorders.”

-Gregory Pontone, MD, Johns Hopkins School of Medicine

Why BRAINWeek?

Today, we know more about brain health than ever before, and experts at BRAINWeek are leveraging that information to create world-class professional education that is rooted in the knowledge of the effects of mental health on physical health, and conversely, the effects of physical health on mental health. By transforming brain health education to address this interconnectivity, we provide expert clinical and actionable education for health care professionals that is unmatched in its scope and depth, and enhances each provider’s expertise.

When & Where:

May 9-11, 2024 (Thursday-Saturday) at the Westin Kierland Resort and Spa – Scottsdale, Arizona  

Who Should Attend?

ALL Healthcare Professionals that are involved in the diagnosing and treatment of patients experiencing brain related conditions.  

Two and a half days of Innovative BRAIN Education – including but not limited to cannabinoid research and application, migraine studies and treatment, mental health disorders, brain health and wellness, and the exploration of psychedelics. There will be 10+ CME/CE credit hours available. 

Upcoming Live Events

BRAINWeek 2024

Smart clinicians choose smart conferences. Experience a week’s worth of education that is meaningful to your practice and patient care!

May 9-11, 2024

The Westin Kierland Resort & Spa

6902 E Greenway Pkwy,                                               

Scottsdale, AZ 85254

Please Call 1-888-236-2427 to book your hotel.


NEW! Explore Our Enduring CME/CE Activities

BRAINWeek Enduring Content

BRAINWeek Bites - Bringing the latest in brain health and wellness innovation.

News & Blogs

How to Master Early Alzheimer’s Detection for Improved Patient Outcomes 

Alzheimer’s Disease: Rising Cases, Lagging Diagnoses, and Undertreatment Currently, about 6.2 million Americans aged 65 and older grapple with Alzheimer’s dementia (AD), a figure set to balloon to 13.8 million by 2060, barring medical breakthroughs to prevent, slow, or cure AD. In 2011, approximately 4.5 million individuals aged sixty-five and above were

Read More »

Exhibit and Sponsorship Opportunities Available

Exhibits & Sponsorships

Robert McCarry
Director, Business Development


Custom Programs Live, Digital, Print

Drew Wilson
VP of International Business Development & Partnerships


Share this event with your community: